292 related articles for article (PubMed ID: 26104564)
41. [Monoclonal antibodies : application of B cell hybridomas to biochemical research (author's transl)].
Tanaka S
Tanpakushitsu Kakusan Koso; 1981 Jul; 26(8):965-76. PubMed ID: 7031777
[No Abstract] [Full Text] [Related]
42. Development of Human Monoclonal Antibodies Against Respiratory Syncytial Virus Using a High Efficiency Human Hybridoma Technique.
Alvarado G; Crowe JE
Methods Mol Biol; 2016; 1442():63-76. PubMed ID: 27464688
[TBL] [Abstract][Full Text] [Related]
43. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
44. Screening of antigen-specific antibody-secreting cells.
Kishi H; Jin A; Ozawa T; Tajiri K; Obata T; Muraguchi A
Methods Mol Biol; 2012; 853():141-50. PubMed ID: 22323145
[TBL] [Abstract][Full Text] [Related]
45. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
46. New strategies to establish human monoclonal antibodies.
Kudo T; Saeki H; Saijyo S; Sato N; Numasaki M; Tachibana T
Tohoku J Exp Med; 1992 Oct; 168(2):323-7. PubMed ID: 1306317
[TBL] [Abstract][Full Text] [Related]
47. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
Gupta KC; Agha R; Santos E; Brodeur BR
Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
[TBL] [Abstract][Full Text] [Related]
48. Electrofusion by a bipolar pulsed electric field: Increased cell fusion efficiency for monoclonal antibody production.
Ke Q; Li C; Wu M; Ge L; Yao C; Yao C; Mi Y
Bioelectrochemistry; 2019 Jun; 127():171-179. PubMed ID: 30831355
[TBL] [Abstract][Full Text] [Related]
49. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
50. Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies.
Koyama K; Akiyama K; Kawahara H; Egashira A; Murakami H
Jpn J Cancer Res; 1990 Oct; 81(10):967-70. PubMed ID: 2121682
[TBL] [Abstract][Full Text] [Related]
51. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
[TBL] [Abstract][Full Text] [Related]
52. Production of stable mouse x human hybridomas secreting HBs antigen-specific human monoclonal antibody by using in vitro sensitization.
Maeda T; Eda Y; Nishiyama K; Ishikawa Y; Tashiro A; Watanabe T
Hybridoma; 1986; 5(1):33-41. PubMed ID: 3957359
[TBL] [Abstract][Full Text] [Related]
53. Development of microfusion techniques to generate human hybridomas.
Foung S; Perkins S; Kafadar K; Gessner P; Zimmermann U
J Immunol Methods; 1990 Nov; 134(1):35-42. PubMed ID: 2172386
[TBL] [Abstract][Full Text] [Related]
54. CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion.
Schmidt E; Leinfelder U; Gessner P; Zillikens D; Bröcker EB; Zimmermann U
J Immunol Methods; 2001 Sep; 255(1-2):93-102. PubMed ID: 11470290
[TBL] [Abstract][Full Text] [Related]
55. [Monoclonal antiprothrombin antibodies from patients with antiphospholipid syndrome].
Horita T
Hokkaido Igaku Zasshi; 2002 Sep; 77(5):397-406. PubMed ID: 12404755
[No Abstract] [Full Text] [Related]
56. Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.
Foung SK; Engleman EG; Grumet FC
Methods Enzymol; 1986; 121():168-74. PubMed ID: 3014266
[No Abstract] [Full Text] [Related]
57. Antibodies and Selection of Monoclonal Antibodies.
Hanack K; Messerschmidt K; Listek M
Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
[TBL] [Abstract][Full Text] [Related]
58. Methods for high frequency production of soluble antigen-specific hybridomas; specificities and affinities of the monoclonal antibodies obtained.
Cianfriglia M; Mariani M; Armellini D; Massone A; Lafata M; Presentini R; Antoni G
Methods Enzymol; 1986; 121():193-210. PubMed ID: 2425215
[No Abstract] [Full Text] [Related]
59. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
Glaser RW; Jahn S; Grunow R
Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
[TBL] [Abstract][Full Text] [Related]
60. Human hybridomas from patients with malignant disease.
Sikora K; Alderson T; Ellis J; Phillips J; Watson J
Br J Cancer; 1983 Jan; 47(1):135-45. PubMed ID: 6336943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
